1. Home
  2. BNTC vs EMX Comparison

BNTC vs EMX Comparison

Compare BNTC & EMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BNTC
  • EMX
  • Stock Information
  • Founded
  • BNTC 1995
  • EMX N/A
  • Country
  • BNTC United States
  • EMX Canada
  • Employees
  • BNTC N/A
  • EMX N/A
  • Industry
  • BNTC Biotechnology: Pharmaceutical Preparations
  • EMX
  • Sector
  • BNTC Health Care
  • EMX
  • Exchange
  • BNTC Nasdaq
  • EMX Nasdaq
  • Market Cap
  • BNTC 335.5M
  • EMX 338.0M
  • IPO Year
  • BNTC N/A
  • EMX N/A
  • Fundamental
  • Price
  • BNTC $13.24
  • EMX $3.65
  • Analyst Decision
  • BNTC Strong Buy
  • EMX Strong Buy
  • Analyst Count
  • BNTC 5
  • EMX 2
  • Target Price
  • BNTC $26.00
  • EMX $5.38
  • AVG Volume (30 Days)
  • BNTC 40.8K
  • EMX 447.8K
  • Earning Date
  • BNTC 09-25-2025
  • EMX 08-11-2025
  • Dividend Yield
  • BNTC N/A
  • EMX N/A
  • EPS Growth
  • BNTC N/A
  • EMX N/A
  • EPS
  • BNTC N/A
  • EMX 0.04
  • Revenue
  • BNTC N/A
  • EMX $29,864,000.00
  • Revenue This Year
  • BNTC N/A
  • EMX $11.08
  • Revenue Next Year
  • BNTC N/A
  • EMX $3.72
  • P/E Ratio
  • BNTC N/A
  • EMX $80.97
  • Revenue Growth
  • BNTC N/A
  • EMX N/A
  • 52 Week Low
  • BNTC $8.06
  • EMX $1.59
  • 52 Week High
  • BNTC $17.15
  • EMX $3.66
  • Technical
  • Relative Strength Index (RSI)
  • BNTC 59.72
  • EMX 74.62
  • Support Level
  • BNTC $12.57
  • EMX $3.04
  • Resistance Level
  • BNTC $13.33
  • EMX $3.37
  • Average True Range (ATR)
  • BNTC 0.60
  • EMX 0.12
  • MACD
  • BNTC 0.10
  • EMX 0.03
  • Stochastic Oscillator
  • BNTC 95.59
  • EMX 97.58

About BNTC Benitec Biopharma Inc.

Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.

About EMX EMX Royalty Corporation (Canada)

EMX Royalty Corp and its subsidiaries operate as a royalty and prospect generator engaged in exploring for and generating royalties from, metals and minerals properties. The company is a precious, and base metals royalty company. The Company augments royalty generation with royalty acquisitions and strategic investments. EMX's royalty and mineral property portfolio consists of properties in North America, Europe, Turkiye, Latin America, Morocco and Australia.

Share on Social Networks: